| 摘要 |
<p>The invention relates to the use of angiogenic agents for the manufacture compositions for the treatment of cellulite, better defined by the term 'edematousfibrosclerotic panniculopathy' to elicit the endothelial repair and/or the neovascularization of the cellulite-affected area and tissues. The invention also claims a method for treating cellulite which comprises the administration of an angiogenic agent, preferably selected from angiogenic phospholipids, hyaluronan oligosaccharides, peptide growth factors and combination thereof and, optionally, secondary angiogenic agents.</p> |
